<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Growing evidence shows that <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> drives the progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Cyclooxygenase-2 (COX-2) is one of the most important inflammatory genes involved in <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumor</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Epidermal growth factor receptor (EGFR) also plays a key role in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell development </plain></SENT>
<SENT sid="3" pm="."><plain>We compared the expression levels of EGFR and COX-2 between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> tissues from 20 CRC patients and studied the molecular mechanism of EGFR-mediated COX-2 gene expression in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>Our results indicated that COX-2 expression was markedly increased after EGF stimulation </plain></SENT>
<SENT sid="5" pm="."><plain>COX-2 promoter analysis indicated the involvement of cyclic <z:chebi fb="47" ids="16027,28971">AMP</z:chebi>-responsive element (CRE) and nuclear factor of activated T cells/nuclear factor interleukin-6 (NFAT/NF-IL6)-binding sites in EGF-mediated signaling pathways </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, EGF-mediated COX-2 activation was prevented by 2-aminoethoxydiphenyl <z:chebi fb="3" ids="22908">borate</z:chebi> (2-APB), a store-operated Ca(2+) channel inhibitor </plain></SENT>
<SENT sid="7" pm="."><plain>Transfection of siRNA against ORAI1 or STIM1, the key regulators of store-operated Ca(2+) channels, showed significant inhibitory effects on EGF-mediated COX-2 expression </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, store-operated Ca(2+) entry is involved in the activation of transcription factors (CREB/NFAT) that are responsible for delivering EGF-mediated signals to evoke inflammatory cascades and is eventually related to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>